Catalyst
Most analysts rate MET Buy or Strong Buy, showing broad institutional optimism.
Fundamental factors such as PB, PB-ROE, and Diluted earnings per share (YoY growth rate %) indicate positive financial health for MET.
A recent MACD Golden Cross signal on November 28 suggests potential for a bullish trend shift.
Risk
Fund flows are negative across all order sizes, indicating a lack of investor confidence in the stock.
The recent MACD Death Cross signal on November 17 indicates a bearish bias for MET.
Technical indicators show that the market is in a volatile state, and the direction is not clear enough, increasing uncertainty for investors.
Generated at21:0012/04/2025by
Aime
